Prediction and validation of common targets in atherosclerosis and non-small cell lung cancer influenced by atorvastatin
Abstract Background Cardiovascular disease and cancer are the main causes of morbidity and mortality worldwide. Studies have shown that these two diseases may have some common risk factors. Atorvastatin is mainly used for the treatment of atherosclerosis in clinic. A large number of studies show tha...
Saved in:
Main Authors: | Yu-qian Li (Author), Lu-yao Li (Author), Xue Yang (Author), Qi-qi Lei (Author), Liu-yan Xiang (Author), Yuan-ru Wang (Author), Si-meng Gu (Author), Ya-jun Cao (Author), Yan Pan (Author), Lu Tie (Author), Xue-jun Li (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Atorvastatin Attenuates Endothelial Cell Injury in Atherosclerosis Through Inhibiting ACSL4-Mediated Ferroptosis
by: Huilian Tan, et al.
Published: (2024) -
Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
by: Xiaoqi Zhao, et al.
Published: (2015) -
Discovery of SIPI6473, a New, Potent, and Orally Bioavailable Multikinase Inhibitor for the Treatment of Non-small Cell Lung Cancer
by: Xiu Gu, et al.
Published: (2021) -
Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
by: Xue Li, et al.
Published: (2022) -
Role of naringin in the treatment of atherosclerosis
by: Yan Lu, et al.
Published: (2024)